Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP vs TPF Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT03604965Phase 3Unknown
- Sponsor
- Guizhou Medical University
- Start
- Jul 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Guizhou Medical University. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03604965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604965.